ID   STK24_HUMAN             Reviewed;         443 AA.
AC   Q9Y6E0; O14840; Q5JV92;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   15-MAR-2017, entry version 169.
DE   RecName: Full=Serine/threonine-protein kinase 24;
DE            EC=2.7.11.1;
DE   AltName: Full=Mammalian STE20-like protein kinase 3;
DE            Short=MST-3;
DE   AltName: Full=STE20-like kinase MST3;
DE   Contains:
DE     RecName: Full=Serine/threonine-protein kinase 24 36 kDa subunit;
DE     AltName: Full=Mammalian STE20-like protein kinase 3 N-terminal;
DE              Short=MST3/N;
DE   Contains:
DE     RecName: Full=Serine/threonine-protein kinase 24 12 kDa subunit;
DE     AltName: Full=Mammalian STE20-like protein kinase 3 C-terminal;
DE              Short=MST3/C;
GN   Name=STK24; Synonyms=MST3, STK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RX   PubMed=9353338; DOI=10.1074/jbc.272.45.28695;
RA   Schinkmann K., Blenis J.;
RT   "Cloning and characterization of a human STE20-like protein kinase
RT   with unusual cofactor requirements.";
RL   J. Biol. Chem. 272:28695-28703(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), PHOSPHORYLATION AT THR-18,
RP   MUTAGENESIS OF THR-18, AND VARIANT VAL-414.
RC   TISSUE=Brain;
RX   PubMed=10644707; DOI=10.1074/jbc.275.4.2513;
RA   Zhou T.-H., Ling K., Guo J., Zhou H., Wu Y.-L., Jing Q., Ma L.,
RA   Pei G.;
RT   "Identification of a human brain-specific isoform of mammalian STE20-
RT   like kinase 3 that is regulated by cAMP-dependent protein kinase.";
RL   J. Biol. Chem. 275:2513-2519(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEOLYTIC PROCESSING, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   LYS-65 AND ASP-321.
RX   PubMed=12107159; DOI=10.1074/jbc.M202468200;
RA   Huang C.Y., Wu Y.M., Hsu C.Y., Lee W.S., Lai M.D., Lu T.J.,
RA   Huang C.L., Leu T.H., Shih H.M., Fang H.I., Robinson D.R., Kung H.J.,
RA   Yuan C.J.;
RT   "Caspase activation of mammalian sterile 20-like kinase 3 (Mst3).";
RL   J. Biol. Chem. 277:34367-34374(2002).
RN   [7]
RP   SUBCELLULAR LOCATION, NUCLEAR LOCALIZATION SIGNAL, AND NUCLEAR EXPORT
RP   SIGNAL.
RX   PubMed=15304321; DOI=10.1016/j.febslet.2004.07.007;
RA   Lee W.S., Hsu C.Y., Wang P.L., Huang C.Y., Chang C.H., Yuan C.J.;
RT   "Identification and characterization of the nuclear import and export
RT   signals of the mammalian Ste20-like protein kinase 3.";
RL   FEBS Lett. 572:41-45(2004).
RN   [8]
RP   COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15917084; DOI=10.1016/j.jinorgbio.2005.03.003;
RA   Lu T.J., Huang C.Y., Yuan C.J., Lee Y.C., Leu T.H., Chang W.C.,
RA   Lu T.L., Jeng W.Y., Lai M.D.;
RT   "Zinc ion acts as a cofactor for serine/threonine kinase MST3 and has
RT   a distinct role in autophosphorylation of MST3.";
RL   J. Inorg. Biochem. 99:1306-1313(2005).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16314523; DOI=10.1128/MCB.25.24.11019-11029.2005;
RA   Stegert M.R., Hergovich A., Tamaskovic R., Bichsel S.J.,
RA   Hemmings B.A.;
RT   "Regulation of NDR protein kinase by hydrophobic motif phosphorylation
RT   mediated by the mammalian Ste20-like kinase MST3.";
RL   Mol. Cell. Biol. 25:11019-11029(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   FUNCTION, PHOSPHORYLATION AT THR-190, AND MUTAGENESIS OF THR-190.
RX   PubMed=17046825; DOI=10.1074/jbc.M605035200;
RA   Lu T.J., Lai W.Y., Huang C.Y., Hsieh W.J., Yu J.S., Hsieh Y.J.,
RA   Chang W.T., Leu T.H., Chang W.C., Chuang W.J., Tang M.J., Chen T.Y.,
RA   Lu T.L., Lai M.D.;
RT   "Inhibition of cell migration by autophosphorylated mammalian sterile
RT   20-like kinase 3 (MST3) involves paxillin and protein-tyrosine
RT   phosphatase-PEST.";
RL   J. Biol. Chem. 281:38405-38417(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 (ISOFORM A), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   FUNCTION, AND PHOSPHORYLATION AT THR-190.
RX   PubMed=19604147; DOI=10.1042/BSR20090096;
RA   Chen C.B., Ng J.K., Choo P.H., Wu W., Porter A.G.;
RT   "Mammalian sterile 20-like kinase 3 (MST3) mediates oxidative-stress-
RT   induced cell death by modulating JNK activation.";
RL   Biosci. Rep. 29:405-415(2009).
RN   [14]
RP   INTERACTION WITH CTTNBP2NL.
RX   PubMed=18782753; DOI=10.1074/mcp.M800266-MCP200;
RA   Goudreault M., D'Ambrosio L.M., Kean M.J., Mullin M.J., Larsen B.G.,
RA   Sanchez A., Chaudhry S., Chen G.I., Sicheri F., Nesvizhskii A.I.,
RA   Aebersold R., Raught B., Gingras A.C.;
RT   "A PP2A phosphatase high density interaction network identifies a
RT   novel striatin-interacting phosphatase and kinase complex linked to
RT   the cerebral cavernous malformation 3 (CCM3) protein.";
RL   Mol. Cell. Proteomics 8:157-171(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2 (ISOFORM A),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 (ISOFORM A), CLEAVAGE
RP   OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM A), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   FUNCTION.
RX   PubMed=19855390; DOI=10.1038/nn.2414;
RA   Lorber B., Howe M.L., Benowitz L.I., Irwin N.;
RT   "Mst3b, an Ste20-like kinase, regulates axon regeneration in mature
RT   CNS and PNS pathways.";
RL   Nat. Neurosci. 12:1407-1414(2009).
RN   [17]
RP   FUNCTION.
RX   PubMed=19782762; DOI=10.1016/j.biocel.2009.09.012;
RA   Lin C.Y., Wu H.Y., Wang P.L., Yuan C.J.;
RT   "Mammalian Ste20-like protein kinase 3 induces a caspase-independent
RT   apoptotic pathway.";
RL   Int. J. Biochem. Cell Biol. 42:98-105(2010).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2 (ISOFORM A),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 (ISOFORM A), CLEAVAGE
RP   OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM A), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2 (ISOFORM A),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 (ISOFORM A), CLEAVAGE
RP   OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM A), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-190, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 27-315 IN COMPLEX WITH
RP   ADENINE; ADP AND MANGANESE IONS, SUBUNIT, AND PHOSPHORYLATION AT
RP   THR-190.
RX   PubMed=20124694; DOI=10.1107/S0907444909047507;
RA   Ko T.P., Jeng W.Y., Liu C.I., Lai M.D., Wu C.L., Chang W.J., Shr H.L.,
RA   Lu T.J., Wang A.H.;
RT   "Structures of human MST3 kinase in complex with adenine, ADP and
RT   Mn2+.";
RL   Acta Crystallogr. D 66:145-154(2010).
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-414 AND ILE-426.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase that acts on both serine
CC       and threonine residues and promotes apoptosis in response to
CC       stress stimuli and caspase activation. Mediates oxidative-stress-
CC       induced cell death by modulating phosphorylation of JNK1-JNK2
CC       (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during
CC       oxidative stress. Plays a role in a staurosporine-induced caspase-
CC       independent apoptotic pathway by regulating the nuclear
CC       translocation of AIFM1 and ENDOG and the DNase activity associated
CC       with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its
CC       kinase activity. Regulates cellular migration with alteration of
CC       PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and
CC       inhibits its activity and may regulate PXN phosphorylation through
CC       PTPN12. May act as a key regulator of axon regeneration in the
CC       optic nerve and radial nerve. {ECO:0000269|PubMed:16314523,
CC       ECO:0000269|PubMed:17046825, ECO:0000269|PubMed:19604147,
CC       ECO:0000269|PubMed:19782762, ECO:0000269|PubMed:19855390}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:15917084};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:15917084};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:15917084};
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:15917084};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=12.8 uM for manganese ions {ECO:0000269|PubMed:15917084};
CC         KM=34.9 uM for cobalt ions {ECO:0000269|PubMed:15917084};
CC         KM=22.7 uM for magnesium ions {ECO:0000269|PubMed:15917084};
CC         KM=4.1 uM for zinc ions {ECO:0000269|PubMed:15917084};
CC         Vmax=2623.1 pmol/min/mg enzyme for manganese ions
CC         {ECO:0000269|PubMed:15917084};
CC         Vmax=1746.1 pmol/min/mg enzyme for cobalt ions
CC         {ECO:0000269|PubMed:15917084};
CC         Vmax=129.1 pmol/min/mg enzyme for magnesium ions
CC         {ECO:0000269|PubMed:15917084};
CC         Vmax=22.3 pmol/min/mg enzyme for zinc ions
CC         {ECO:0000269|PubMed:15917084};
CC   -!- SUBUNIT: Monomer. Interacts with CTTNBP2NL.
CC       {ECO:0000269|PubMed:18782753, ECO:0000269|PubMed:20124694}.
CC   -!- INTERACTION:
CC       Q9P2B4:CTTNBP2NL; NbExp=4; IntAct=EBI-740175, EBI-1774273;
CC       Q9BUL8:PDCD10; NbExp=7; IntAct=EBI-740175, EBI-740195;
CC       O43815:STRN; NbExp=3; IntAct=EBI-740175, EBI-1046642;
CC       Q9Y228:TRAF3IP3; NbExp=2; IntAct=EBI-740175, EBI-765817;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Membrane. Note=The
CC       truncated form (MST3/N) translocates to the nucleus. Colocalizes
CC       with STK38L in the membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=B;
CC         IsoId=Q9Y6E0-1; Sequence=Displayed;
CC       Name=A;
CC         IsoId=Q9Y6E0-2; Sequence=VSP_004874;
CC         Note=Contains a phosphoserine at position 4. Initiator Met-1 is
CC         removed. Contains a N-acetylalanine at position 2.
CC         {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195,
CC         ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692};
CC   -!- TISSUE SPECIFICITY: Isoform A is ubiquitous. Isoform B is
CC       expressed in brain with high expression in hippocampus and
CC       cerebral cortex.
CC   -!- PTM: Proteolytically processed by caspases during apoptosis.
CC       Proteolytic cleavage results in kinase activation, nuclear
CC       translocation of the truncated form (MST3/N) and the induction of
CC       apoptosis. {ECO:0000269|PubMed:12107159}.
CC   -!- PTM: Isoform B is activated by phosphorylation by PKA. Oxidative
CC       stress induces phosphorylation. Activated by autophosphorylation
CC       at Thr-190 and phosphorylation at this site is essential for its
CC       function. Manganese, magnesium and cobalt-dependent
CC       autophosphorylation is mainly on threonine residues while zinc-
CC       dependent autophosphorylation is on both serine and threonine
CC       residues. {ECO:0000269|PubMed:10644707,
CC       ECO:0000269|PubMed:17046825, ECO:0000269|PubMed:19604147,
CC       ECO:0000269|PubMed:20124694}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF024636; AAB82560.1; -; mRNA.
DR   EMBL; AF083420; AAD42039.1; -; mRNA.
DR   EMBL; AL356423; CAI13114.1; -; Genomic_DNA.
DR   EMBL; AL137249; CAI13114.1; JOINED; Genomic_DNA.
DR   EMBL; AL137249; CAI39453.1; -; Genomic_DNA.
DR   EMBL; AL356423; CAI39453.1; JOINED; Genomic_DNA.
DR   EMBL; CH471085; EAX08986.1; -; Genomic_DNA.
DR   EMBL; BC035578; AAH35578.1; -; mRNA.
DR   CCDS; CCDS32001.1; -. [Q9Y6E0-2]
DR   CCDS; CCDS9488.1; -. [Q9Y6E0-1]
DR   RefSeq; NP_001027467.2; NM_001032296.3. [Q9Y6E0-2]
DR   RefSeq; NP_003567.2; NM_003576.4. [Q9Y6E0-1]
DR   UniGene; Hs.508514; -.
DR   PDB; 3A7F; X-ray; 1.55 A; A=27-315.
DR   PDB; 3A7G; X-ray; 2.00 A; A/B=27-315.
DR   PDB; 3A7H; X-ray; 1.96 A; A/B=27-315.
DR   PDB; 3A7I; X-ray; 1.45 A; A=27-315.
DR   PDB; 3A7J; X-ray; 1.50 A; A=27-315.
DR   PDB; 3CKW; X-ray; 1.96 A; A=31-323.
DR   PDB; 3CKX; X-ray; 2.70 A; A=31-323.
DR   PDB; 3ZHP; X-ray; 2.90 A; C/D=31-301.
DR   PDB; 4O27; X-ray; 3.19 A; B=30-309.
DR   PDB; 4QML; X-ray; 1.88 A; A=24-315.
DR   PDB; 4QMM; X-ray; 1.85 A; A=24-315.
DR   PDB; 4QMN; X-ray; 2.09 A; A=27-315.
DR   PDB; 4QMO; X-ray; 1.90 A; A=24-315.
DR   PDB; 4QMP; X-ray; 2.00 A; A=24-315.
DR   PDB; 4QMQ; X-ray; 1.77 A; A=24-315.
DR   PDB; 4QMS; X-ray; 1.88 A; A=24-315.
DR   PDB; 4QMT; X-ray; 1.50 A; A=24-315.
DR   PDB; 4QMU; X-ray; 1.55 A; A=24-315.
DR   PDB; 4QMV; X-ray; 2.40 A; A=24-315.
DR   PDB; 4QMW; X-ray; 1.60 A; A=24-315.
DR   PDB; 4QMX; X-ray; 1.88 A; A=24-315.
DR   PDB; 4QMY; X-ray; 1.88 A; A=24-315.
DR   PDB; 4QMZ; X-ray; 1.88 A; A=24-315.
DR   PDB; 4QNA; X-ray; 1.85 A; A=27-315.
DR   PDB; 4QO9; X-ray; 2.20 A; A/B=24-315.
DR   PDB; 4U8Z; X-ray; 1.63 A; A=24-310.
DR   PDB; 4W8D; X-ray; 1.77 A; A=24-310.
DR   PDB; 4W8E; X-ray; 1.79 A; A=24-311.
DR   PDBsum; 3A7F; -.
DR   PDBsum; 3A7G; -.
DR   PDBsum; 3A7H; -.
DR   PDBsum; 3A7I; -.
DR   PDBsum; 3A7J; -.
DR   PDBsum; 3CKW; -.
DR   PDBsum; 3CKX; -.
DR   PDBsum; 3ZHP; -.
DR   PDBsum; 4O27; -.
DR   PDBsum; 4QML; -.
DR   PDBsum; 4QMM; -.
DR   PDBsum; 4QMN; -.
DR   PDBsum; 4QMO; -.
DR   PDBsum; 4QMP; -.
DR   PDBsum; 4QMQ; -.
DR   PDBsum; 4QMS; -.
DR   PDBsum; 4QMT; -.
DR   PDBsum; 4QMU; -.
DR   PDBsum; 4QMV; -.
DR   PDBsum; 4QMW; -.
DR   PDBsum; 4QMX; -.
DR   PDBsum; 4QMY; -.
DR   PDBsum; 4QMZ; -.
DR   PDBsum; 4QNA; -.
DR   PDBsum; 4QO9; -.
DR   PDBsum; 4U8Z; -.
DR   PDBsum; 4W8D; -.
DR   PDBsum; 4W8E; -.
DR   ProteinModelPortal; Q9Y6E0; -.
DR   SMR; Q9Y6E0; -.
DR   BioGrid; 114011; 77.
DR   DIP; DIP-40608N; -.
DR   IntAct; Q9Y6E0; 36.
DR   MINT; MINT-3088034; -.
DR   STRING; 9606.ENSP00000365730; -.
DR   BindingDB; Q9Y6E0; -.
DR   ChEMBL; CHEMBL5082; -.
DR   GuidetoPHARMACOLOGY; 2217; -.
DR   iPTMnet; Q9Y6E0; -.
DR   PhosphoSitePlus; Q9Y6E0; -.
DR   SwissPalm; Q9Y6E0; -.
DR   DMDM; 13626607; -.
DR   EPD; Q9Y6E0; -.
DR   PaxDb; Q9Y6E0; -.
DR   PeptideAtlas; Q9Y6E0; -.
DR   PRIDE; Q9Y6E0; -.
DR   DNASU; 8428; -.
DR   Ensembl; ENST00000376547; ENSP00000365730; ENSG00000102572. [Q9Y6E0-1]
DR   Ensembl; ENST00000539966; ENSP00000442539; ENSG00000102572. [Q9Y6E0-2]
DR   GeneID; 8428; -.
DR   KEGG; hsa:8428; -.
DR   UCSC; uc001vnm.3; human. [Q9Y6E0-1]
DR   CTD; 8428; -.
DR   DisGeNET; 8428; -.
DR   GeneCards; STK24; -.
DR   HGNC; HGNC:11403; STK24.
DR   HPA; HPA026435; -.
DR   HPA; HPA026502; -.
DR   MIM; 604984; gene.
DR   neXtProt; NX_Q9Y6E0; -.
DR   OpenTargets; ENSG00000102572; -.
DR   PharmGKB; PA36210; -.
DR   eggNOG; KOG0201; Eukaryota.
DR   eggNOG; ENOG410XP9G; LUCA.
DR   GeneTree; ENSGT00810000125395; -.
DR   HOGENOM; HOG000234203; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; Q9Y6E0; -.
DR   KO; K08838; -.
DR   OMA; RAQLWGL; -.
DR   OrthoDB; EOG091G0F24; -.
DR   PhylomeDB; Q9Y6E0; -.
DR   TreeFam; TF354217; -.
DR   Reactome; R-HSA-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-HSA-75153; Apoptotic execution phase.
DR   SignaLink; Q9Y6E0; -.
DR   SIGNOR; Q9Y6E0; -.
DR   ChiTaRS; STK24; human.
DR   EvolutionaryTrace; Q9Y6E0; -.
DR   GeneWiki; STK24; -.
DR   GenomeRNAi; 8428; -.
DR   PRO; PR:Q9Y6E0; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000102572; -.
DR   CleanEx; HS_STK24; -.
DR   CleanEx; HS_STK3; -.
DR   ExpressionAtlas; Q9Y6E0; baseline and differential.
DR   Genevisible; Q9Y6E0; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0097194; P:execution phase of apoptosis; IMP:UniProtKB.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048679; P:regulation of axon regeneration; IMP:UniProtKB.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis;
KW   ATP-binding; Complete proteome; Cytoplasm; Kinase; Magnesium;
KW   Membrane; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    443       Serine/threonine-protein kinase 24.
FT                                /FTId=PRO_0000086711.
FT   CHAIN         1    325       Serine/threonine-protein kinase 24 36 kDa
FT                                subunit.
FT                                /FTId=PRO_0000413618.
FT   CHAIN       326    443       Serine/threonine-protein kinase 24 12 kDa
FT                                subunit.
FT                                /FTId=PRO_0000413619.
FT   DOMAIN       36    286       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      42     50       ATP.
FT   NP_BIND     112    114       ATP.
FT   MOTIF       278    292       Bipartite nuclear localization signal.
FT   MOTIF       335    386       Nuclear export signal (NES).
FT   ACT_SITE    156    156       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   METAL       161    161       Magnesium.
FT   METAL       174    174       Magnesium.
FT   BINDING      65     65       ATP.
FT   SITE        325    326       Cleavage; by caspase-3, caspase-7 and
FT                                caspase-8.
FT   MOD_RES      18     18       Phosphothreonine; by PKA.
FT                                {ECO:0000269|PubMed:10644707}.
FT   MOD_RES     190    190       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:17046825,
FT                                ECO:0000269|PubMed:19604147,
FT                                ECO:0000269|PubMed:20124694}.
FT   MOD_RES     320    320       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983}.
FT   VAR_SEQ       1     26       MDSRAQLWGLALNKRRATLPHPGGST -> MAHSPVQSGLP
FT                                GMQ (in isoform A).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9353338}.
FT                                /FTId=VSP_004874.
FT   VARIANT     414    414       A -> V (in dbSNP:rs55953606).
FT                                {ECO:0000269|PubMed:10644707,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041148.
FT   VARIANT     426    426       L -> I (in dbSNP:rs55897869).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041149.
FT   MUTAGEN      18     18       T->A: Loss of phosphorylation by PKA.
FT                                {ECO:0000269|PubMed:10644707}.
FT   MUTAGEN      65     65       K->A: Loss of activity and
FT                                autophosphorylation.
FT                                {ECO:0000269|PubMed:12107159}.
FT   MUTAGEN     190    190       T->A: Loss of activity and
FT                                autophosphorylation.
FT                                {ECO:0000269|PubMed:17046825}.
FT   MUTAGEN     321    321       D->N: Loss of proteolytic cleavage by
FT                                caspases. {ECO:0000269|PubMed:12107159}.
FT   TURN         24     27       {ECO:0000244|PDB:4W8E}.
FT   HELIX        32     34       {ECO:0000244|PDB:3A7I}.
FT   STRAND       36     44       {ECO:0000244|PDB:3A7I}.
FT   STRAND       46     55       {ECO:0000244|PDB:3A7I}.
FT   TURN         56     58       {ECO:0000244|PDB:3A7I}.
FT   STRAND       61     68       {ECO:0000244|PDB:3A7I}.
FT   TURN         69     71       {ECO:0000244|PDB:3A7I}.
FT   TURN         73     75       {ECO:0000244|PDB:4QMT}.
FT   HELIX        76     88       {ECO:0000244|PDB:3A7I}.
FT   STRAND       97    103       {ECO:0000244|PDB:3A7I}.
FT   STRAND      106    112       {ECO:0000244|PDB:3A7I}.
FT   STRAND      116    118       {ECO:0000244|PDB:3A7J}.
FT   HELIX       119    123       {ECO:0000244|PDB:3A7I}.
FT   STRAND      124    126       {ECO:0000244|PDB:3A7H}.
FT   HELIX       130    149       {ECO:0000244|PDB:3A7I}.
FT   HELIX       159    161       {ECO:0000244|PDB:3A7I}.
FT   STRAND      162    164       {ECO:0000244|PDB:3A7I}.
FT   STRAND      166    168       {ECO:0000244|PDB:3ZHP}.
FT   STRAND      170    172       {ECO:0000244|PDB:3A7I}.
FT   STRAND      183    185       {ECO:0000244|PDB:4QO9}.
FT   STRAND      186    188       {ECO:0000244|PDB:4QMQ}.
FT   HELIX       195    197       {ECO:0000244|PDB:3A7I}.
FT   HELIX       200    203       {ECO:0000244|PDB:3A7I}.
FT   HELIX       211    226       {ECO:0000244|PDB:3A7I}.
FT   TURN        230    233       {ECO:0000244|PDB:3A7I}.
FT   HELIX       236    245       {ECO:0000244|PDB:3A7I}.
FT   STRAND      253    255       {ECO:0000244|PDB:4QML}.
FT   HELIX       257    266       {ECO:0000244|PDB:3A7I}.
FT   HELIX       271    273       {ECO:0000244|PDB:3A7I}.
FT   HELIX       277    280       {ECO:0000244|PDB:3A7I}.
FT   HELIX       284    289       {ECO:0000244|PDB:3A7I}.
FT   HELIX       293    296       {ECO:0000244|PDB:3A7I}.
FT   HELIX       297    309       {ECO:0000244|PDB:3A7I}.
SQ   SEQUENCE   443 AA;  49308 MW;  4A9FF1F6B6A88A97 CRC64;
     MDSRAQLWGL ALNKRRATLP HPGGSTNLKA DPEELFTKLE KIGKGSFGEV FKGIDNRTQK
     VVAIKIIDLE EAEDEIEDIQ QEITVLSQCD SPYVTKYYGS YLKDTKLWII MEYLGGGSAL
     DLLEPGPLDE TQIATILREI LKGLDYLHSE KKIHRDIKAA NVLLSEHGEV KLADFGVAGQ
     LTDTQIKRNT FVGTPFWMAP EVIKQSAYDS KADIWSLGIT AIELARGEPP HSELHPMKVL
     FLIPKNNPPT LEGNYSKPLK EFVEACLNKE PSFRPTAKEL LKHKFILRNA KKTSYLTELI
     DRYKRWKAEQ SHDDSSSEDS DAETDGQASG GSDSGDWIFT IREKDPKNLE NGALQPSDLD
     RNKMKDIPKR PFSQCLSTII SPLFAELKEK SQACGGNLGS IEELRGAIYL AEEACPGISD
     TMVAQLVQRL QRYSLSGGGT SSH
//
